.

Rigel Pharmaceuticals reported $149.07M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agenus AGEN:US $ 456.17M 14.87M
Amgen AMGN:US $ 59294M 98M
Anika Therapeutics ANIK:US $ 354.12M 11.88M
Applied Genetic Technologies AGTC:US $ 66.68M 20.51M
Arrowhead Research ARWR:US $ 751.78M 48.21M
AstraZeneca AZN:LN 7932612.74M 297425.43M
Astrazeneca AZN:US $ 96579M 3694M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Chemocentryx CCXI:US $ 419.39M 21.06M
Daiichi Sankyo 4568:JP Y 2294549M 73147M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Halozyme Therapeutics HALO:US $ 1781.39M 619.14M
Heron Therapeutics HRTX:US $ 243.96M 29.76M
Immunogen IMGN:US $ 422.3M 59.41M
Intrexon XON:US $ 321.22M 14.34M
IONIS PHARMACEUT IONS:US $ 2456.13M 62.96M
Karyopharm Therapeutics KPTI:US $ 256.48M 37.56M
Ligand Pharmaceuticals LGND:US $ 1076.29M 28.9M
Macrogenics MGNX:US $ 218.04M 53.4M
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M
Veracyte VCYT:US $ 1144.2M 29.39M